Filtered By:
Specialty: Drugs & Pharmacology
Condition: Thrombosis
Countries: Taiwan Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Effect Modification by Indication to the Risks of Major Thromboembolic Adverse Events in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment: A Population-Based Retrospective Cohort Study
ConclusionsPatients treated with aflibercept or ranibizumab for different indications may be associated with varying risk of TAEs. The findings provide evidence to support treatment selection, taking indications and TAE risk into consideration.
Source: BioDrugs - March 1, 2022 Category: Drugs & Pharmacology Source Type: research
